Robert T Manguso

发表

Primary cilia and aberrant cell signaling in epithelial ovarian cancer

T. S. Jørgensen, Aashir Awan, L. Pedersen, 2012, Cilia.

In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target

John G. Doench, David E. Root, David E. Fisher, 2017, Nature.

In Vivo Genetic Screening to Identify Mechanisms of Resistance to Cancer Immunotherapy

Robert T Manguso, Robert T. Manguso, 2017 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

F. Hodi, W. Haining, K. Yates, 2019, Nature Immunology.

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

John G Doench, J. Doench, E. Levanon, 2018, Nature.

EB1 and EB3 promote cilia biogenesis by several centrosome-related mechanisms

A. Akhmanova, S. Geimer, S. Pedersen, 2011, Journal of Cell Science.

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

N. Hacohen, Dennie T. Frederick, D. Root, 2022, Nature Immunology.

Tumor-Derived PGE2 Gives NK Cells a Headache.

Nelson H. Knudsen, Robert T Manguso, 2020, Immunity.

An expanded universe of cancer targets

Hanlee P. Ji, Michael T. McManus, Joshua M. Dempster, 2021, Cell.